Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    GENTIAN VIOLET
Show Display Options
Rank Status Study
1 Completed A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis
Condition: Candidiasis, Oral
Interventions: Drug: Gentian violet 1% solution;   Drug: Gentian violet  0.00165% solution;   Drug: Nystatin solution
2 Completed
Has Results
Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis
Condition: HIV-1 Infection
Interventions: Drug: Gentian Violet;   Drug: Nystatin oral suspension

Indicates status has not been verified in more than two years